Hemoglobin A1c Testing Market Survey by Product Types, Segment Applications, Company Pricing, Offers & Consumptions To 2022-2030

The global hemoglobin A1c testing market for the historical year of 2017 and forecast period of 2019 to 2027, increase in the demand for point-of-care testing for the diagnosis of diabetes, high prevalence of diabetes, and launch of automated hemoglobin A1c testing analyzers are expected to boost the growth of the global hemoglobin A1c testing market during the forecast period.

The global hemoglobin A1c testing market was valued at ~US$ 1 Bn in 2018, and is expected to expand at a CAGR of ~9% during the forecast period.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111771

Increase in Prevalence of Diabetes: A Key Driver

Diabetes is a common health condition among the geriatric population, the prevalence of which is expected to increase over the next few years. This high prevalence of diabetes is expected to drive the growth of the hemoglobin A1c testing market during the forecast period.

According to the National Institutes of Health, 8.5% of the people (617 million) across the world were aged 65 years or above in 2016, and this percentage is projected to increase to nearly 17% (1.6 billion) by 2050.

In Europe, there has been an exponential increase in the number of patients with diabetes. This can be attributed to obesity, sedentary lifestyle, and unhealthy diet among adults in the region.

According to the International Diabetes Federation, over 66 million people had diabetes in Europe in 2017, and the number is likely to rise to 81 million by 2045. There were 7,476,800 cases of diabetes in Germany in 2017. Furthermore, 286,000 children had diabetes in 2017, and each year, 28,600 children are diagnosed with diabetes.

These factors have led to the increase in healthcare expenditure, which was US$ 207 Bn in 2017, and is likely to increase to US$ 214 Bn by 2045.

Popularity of Ion-exchange High Performance Liquid Chromatography (HPLC)

The ion-exchange high performance liquid chromatography (HPLC) segment dominated the global hemoglobin A1c testing market in 2018, and is expected to account for the largest market share during the forecast period, as this technology is most widely used for hemoglobin A1c testing, and provides accurate HbA1c values in the presence of hemoglobin variants in case of a highly diversified population. HPLC increases the ionic strength of buffer, identifies variants, and consumes less time.

Most of the devices available in the market are based on HPLC, and the technology is preferred for hemoglobin A1c testing. HPLC-based hemoglobin A1c testing analyzers can also be used in point-of-care settings, along with laboratories. In December 2015, ARKRAY, Inc. launched a glucose analyzer named ‘ADAMS Glucose GA-1172’, and a glycohemoglobin analyzer called ‘ADAMS A1c HA-8182’, to determine blood sugar and hemoglobin A1c levels in patients. The glycohemoglobin analyzer ADAMS A1c HA-8182 is based on HPLC, and provides accurate results.

North America Prominent Hemoglobin A1c Testing Market

North America accounted for a major share of the global hemoglobin A1c testing market in 2018, followed by Europe. Increase in the number of point-of-care testing analyzers receiving approval from the Food & Drug Administration (FDA), new product launches, and rise in the adoption of newer technologies for hemoglobin A1c testing are various factors that are expected to drive the hemoglobin A1c testing market in the region.

In January 2019, PTS Diagnostics announced that the U.S. Food and Drug Administration (FDA) had cleared a medical device convenience kit that quantitatively measures the percent of glycated hemoglobin, total cholesterol, high-density lipoprotein, triglycerides, and glucose in whole blood.

In April 2014, Abbott Laboratories received FDA approval for ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test to help physicians in diagnosing and monitoring diabetes.

In Europe, the hemoglobin A1c testing market is expected to gain traction during the forecast period. The growth of the market in the region can be attributed to the increase in prevalence of diabetes, product approvals in the European Union (EU), and availability of automated hemoglobin A1c analyzers for laboratory settings.

In January 2018, Abbott Laboratories received CE approval for new Alinity h-series integrated system for hematology A1c testing. New Alinity h-series has combined features of Alinity hq and Alinity hs.

In April 2018, Beckman Coulter obtained CE mark for its DxH 520 hematology analyzer, which is a closed-tube, 5-part differential system for small-volume labs. In April 2018, ABL9 blood analyzers won the ‘IF DESIGN AWARD 2018’.

The hemoglobin A1c testing market in Asia Pacific is estimated to grow at a faster pace than other regions during the forecast period, due to increase in the number of laboratory testing for diabetes, presence of well-qualified healthcare staff such as diabetologists and clinicians, and growing burden of diabetes.

View full report@ https://qyresearchmedical.com/report/hemoglobin-a1c-testing-market-technology-ion-exchange-high-performance-liquid-chromatography-hplc-immunoassays-boronate-affinity-chromatography-direct-enzymatic-assays-others-end-user-laboratory-testing-c-019-2030/111771

According to the International Diabetes Federation (IDF), approximately 382 million people across the globe are expected to have diabetes by 2035, and of these, 60% will live in Asia and one-third in China.

Global Hemoglobin A1c Testing Market: Competition Landscape

Detailed profiles of manufacturers of hemoglobin A1c testing have been provided in the report to evaluate their key product offerings, financials, business strategies, and recent developments.

Key players operating in the global hemoglobin A1c testing market include

  • Abbott Laboratories
  • ARKRAY, Inc.
  • Bio-Rad Laboratories, Inc.
  • Polymer Technology Systems, Inc.
  • Danaher Corporation (Beckman Coulter)
  • F. Hoffmann-La Roche Ltd.
  • Menarini Group
  • Sebia
  • Siemens Healthineers
  • Tosoh Corporation
  • Trinity Biotech plc.

Key Questions Answered in TMR’s Hemoglobin A1c Testing Market Study

  • What is the scope of growth of hemoglobin A1c testing companies in the pharmaceutical drugs sector?
  • What will be the Y-o-Y growth of the hemoglobin A1c testing market between 2019 and 2027?
  • What is the influence of changing trends on the global hemoglobin A1c testing market?
  • Will North America continue to remain the most profitable regional market for hemoglobin A1c testing providers?
  • Which factors will impede the growth of the global hemoglobin A1c testing market during the forecast period?
  • Which are the leading companies in the global hemoglobin A1c testing market?

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111771/2900

Segmentation of Global Hemoglobin A1c Testing Market

Technology

  • Ion-Exchange High Performance Liquid Chromatography (HPLC)
  • Immunoassays
  • Boronate Affinity Chromatography
  • Direct Enzymatic Assays
  • Others

End User

  • Laboratory Testing
  • Commercial Laboratories
  • Others
  • Point-of-Care (POC) Testing
  • Hospitals
  • Homecare
  • Clinics
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Hemoglobin  A1c Testing Market

3.1. Market Overview

3.2. Introduction

3.3. Product Definition

3.4. Industry Evolution / Developments

4. Overview

4.1. Market Dynamics

4.1.1. Drivers

4.1.2. Restraints

4.1.3. Opportunities

4.2. Global Hemoglobin A1c Testing Market Analysis and Forecast, 2017–2027

5. Key Insights

5.1. Recent Approved Brands for HbA1c Test, 2018

5.2. Global Hemoglobin A1c Testing Market: Regulations

5.3. Quantitative Analysis, by Test Type

5.4. Europe Hemoglobin A1c Testing Market Overview

6. Global Hemoglobin  A1c Testing Market Analysis and Forecast, by Technology

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Global Hemoglobin  A1c Testing Market Value Forecast, by Technology, 2017–2027

6.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)

6.3.2. Immunoassay

6.3.3. Boronate Affinity Chromatography

6.3.4. Direct Enzymatic Assay

6.3.5. Others

6.4. Global Hemoglobin  A1c Testing Market Attractiveness, by Technology

7. Global Hemoglobin  A1c Testing Market Analysis and Forecast, by End-user

7.1. Introduction & Definition

7.2. Key Findings / Developments

7.3. Global Hemoglobin  A1c Testing Market Value Forecast, by End-user, 2017–2027

7.3.1. Laboratory Testing

7.3.1.1. Commercial Laboratory

7.3.1.2. Others

7.3.2. Point-of-Care (POC) Testing

7.3.2.1. Hospitals

7.3.2.2. Homecare

7.3.2.3. Clinics

7.3.2.4. Others

7.4. Global Hemoglobin  A1c Testing Market Attractiveness, by End-user

8. Global Hemoglobin  A1c Testing Market Analysis and Forecast, by Region

8.1. Key Findings

8.2. Global Hemoglobin  A1c Testing Market Value Forecast, by Region

8.2.1. North America

8.2.2. Europe

8.2.3. Asia Pacific

8.2.4. Latin America

8.2.5. Middle East & Africa

8.3. Global Hemoglobin  A1c Testing Market Attractiveness, by Region

9. North America Hemoglobin  A1c Testing Market Analysis and Forecast

9.1. Introduction

9.2. Key Findings

9.3. North America Hemoglobin  A1c Testing Market Value Forecast, by Technology, 2017–2027

9.3.1. Ion-Exchange High Performance Liquid Chromatography (HPLC)

9.3.2. Immunoassay

9.3.3. Boronate Affinity Chromatography

9.3.4. Direct Enzymatic Assay

9.3.5. Others

9.4. North America Hemoglobin  A1c Testing Market Value Forecast, by End-user, 2017–2027

9.4.1. Laboratory Testing

9.4.1.1. Commercial Laboratory

9.4.1.2. Others

9.4.2. Point-of-Care (POC) Testing

9.4.2.1. Hospitals

9.4.2.2. Homecare

9.4.2.3. Clinics

9.4.2.4. Others

9.5. North America Hemoglobin  A1c Testing Market Value Forecast, by Country, 2017–2027

9.5.1. 1. U.S.

9.5.2. Canada

9.6. North America Hemoglobin  A1c Testing Market Attractiveness Analysis

9.6.1. By Technology

9.6.2. By End-user

9.6.3. By Country

10. Europe Hemoglobin  A1c Testing Market Analysis and Forecast

……

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111771/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi